Thermo Fisher Scientific (TMO) Tops Q4 EPS by 3c, Beats on Revenue; Offers Guidance

Thermo Fisher Scientific (NYSE: TMO) reported Q4 EPS of $5.67, $0.03 better than the analyst estimate of $5.64. Revenue for the quarter came in at $10.89 billion versus the consensus estimate of $10.73 billion.

Thermo Fisher is initiating a guidance range for full year 2024 with revenue of $42.1 billion to $43.3 billion and adjusted EPS of $20.95 to $22.00.

For earnings history and earnings-related data on Thermo Fisher Scientific (TMO) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• MeiraGTx Holdings plc (MGTX) Tops Q2 EPS by 202c
• Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation